The £5.1m financing values the personal data platform at £30m and includes backing from high-profile figures such as Chris Gayle.
"We believe Gener8 is the first company in the world to enable people to centralise their data into one location and earn from it. We’ve built something that, until now, has only been theoretical in the world of academia"
The investment from BGF will support the expansion of Recite Me and its assistive technology.
"We pioneered the assistive technology sector when we launched over a decade ago and have successfully grown the business to be a market leader, but our mission doesn’t stop here as we aim to help millions of people access online content around the world. To galvanise our growth, we were looking for investment partners who shared our values and ambitions and brought their experience of scaling businesses to the next level. BGF was the obvious choice, and we look forward to working with them to invest further in our technology, team and infrastructure so our tech can benefit even more people across the world."
Oxford Innovation and OION angels have backed Cognitant Group in a follow-on funding round.
"We are focused on making it easier for patients to understand their symptoms and management of their individual condition. This not only has a positive impact on their overall health, but it also allows them to successfully make decisions about their individual treatment plans in collaboration with their clinicians. Our partnerships with global pharmaceutical companies, the NHS and other healthcare providers, is making real and valuable changes to the way patients engage with and manage their health."
QVentures led the pre-seed round with backing from Episode1 and industry angels to support the Meristem platform.
"Clinical trials are to medicine what elections are to democracy; they are the definitive process behind every significant step forwards and how we reason about what is effective and safe and what is not."